[go: up one dir, main page]

IL139965A0 - Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway and inhibitors of lipid metabolism - Google Patents

Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway and inhibitors of lipid metabolism

Info

Publication number
IL139965A0
IL139965A0 IL13996599A IL13996599A IL139965A0 IL 139965 A0 IL139965 A0 IL 139965A0 IL 13996599 A IL13996599 A IL 13996599A IL 13996599 A IL13996599 A IL 13996599A IL 139965 A0 IL139965 A0 IL 139965A0
Authority
IL
Israel
Prior art keywords
methylerythrose
inhibitors
inhibit
active compounds
lipid metabolism
Prior art date
Application number
IL13996599A
Original Assignee
Jomaa Hassan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19828097A external-priority patent/DE19828097A1/en
Application filed by Jomaa Hassan filed Critical Jomaa Hassan
Publication of IL139965A0 publication Critical patent/IL139965A0/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Food Science & Technology (AREA)
IL13996599A 1998-06-24 1999-06-23 Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway and inhibitors of lipid metabolism IL139965A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19828097A DE19828097A1 (en) 1998-06-24 1998-06-24 Identifying antiparasitic agents used to treat or prevent parasitic infections, especially malaria, sleeping sickness and leishmaniosis
DE19843279 1998-09-22
PCT/EP1999/004360 WO1999066875A2 (en) 1998-06-24 1999-06-23 Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism

Publications (1)

Publication Number Publication Date
IL139965A0 true IL139965A0 (en) 2002-02-10

Family

ID=26047010

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13996599A IL139965A0 (en) 1998-06-24 1999-06-23 Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway and inhibitors of lipid metabolism

Country Status (10)

Country Link
EP (1) EP1100510A2 (en)
JP (1) JP2002518418A (en)
CN (1) CN1348374A (en)
AU (1) AU752714B2 (en)
CA (1) CA2334645A1 (en)
IL (1) IL139965A0 (en)
PL (1) PL345513A1 (en)
SK (1) SK19612000A3 (en)
TR (1) TR200003783T2 (en)
WO (1) WO1999066875A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100724004B1 (en) 1998-04-14 2007-06-04 교와 학꼬 고교 가부시키가이샤 Searching for substances with antibacterial or herbicidal activity
WO2015127259A1 (en) * 2014-02-23 2015-08-27 Fmc Corporation Use of 3-isoxazolidinones compounds as selective herbicides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4330529A (en) * 1978-02-15 1982-05-18 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition
JPS6064991A (en) * 1983-09-17 1985-04-13 Fujisawa Pharmaceut Co Ltd Cephalexin-fosmidomycin salt and its preparation
US4846872A (en) * 1986-08-11 1989-07-11 Fujisawa Pharmaceutical Co., Ltd. Herbicide
JPH05163150A (en) * 1991-05-13 1993-06-29 E R Squibb & Sons Inc Suppressant/remedy against atherromatous arteriosclerosis
CA2080158A1 (en) * 1991-10-11 1993-04-12 Scott A. Biller Method for blocking neoplastic transformation of cells induced by ras oncogenes employing bisphosphonates or analogs thereof

Also Published As

Publication number Publication date
AU4615599A (en) 2000-01-10
SK19612000A3 (en) 2001-08-06
WO1999066875A2 (en) 1999-12-29
PL345513A1 (en) 2001-12-17
CN1348374A (en) 2002-05-08
AU752714B2 (en) 2002-09-26
EP1100510A2 (en) 2001-05-23
JP2002518418A (en) 2002-06-25
WO1999066875A3 (en) 2000-09-14
TR200003783T2 (en) 2001-06-21
CA2334645A1 (en) 1999-12-29

Similar Documents

Publication Publication Date Title
HUP0103707A3 (en) Formulation of stable oxalyplatinum solution
HUP0103464A3 (en) Prodrugs of proton pump inhibitors and pharmaceutical compositions containing them
AU4217499A (en) Composition having therapeutic and/or nutritionally active substituent
IL139321A0 (en) Methods and compositions for modulating lipid metabolism
HUP0105089A3 (en) Compositions containing the active ingredient in form dispersible phospholipid stabilized microparticles
TW370888U (en) Structure of roller stand of roller skate
HUP0101461A3 (en) Novel pyridazine derivatives and drugs containing the same as the active ingredient
HUP0003705A3 (en) Analgesic compositions comprising anti-epileptic compounds and methods of using same
IL137928A0 (en) Dietary control of arachidonic acid metabolism
IL123232A0 (en) Medicament for inhibiting glucose metabolism deterioration
EG24225A (en) Solid lipid formulations
NO20011459D0 (en) Genes in the biosynthesis pathway of 1-deoxy-D-xylulose
IL140667A0 (en) Compositions containing at least one active substance having an influence on the levels of lipids in the blood
PL349393A1 (en) Sulphonyloxazolamines as therapeutic active ingredients
AU2002328402A1 (en) Carba-sugar amine derivatives and treatments for disorder of glycolipid metabolism containing the same as the active ingredient
IL139965A0 (en) Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway and inhibitors of lipid metabolism
HUP9802716A3 (en) Pharmaceutical composition of analgesic activity
AU5682900A (en) Combination of mtp inhibitors and active agents that influence the metabolism and use thereof in medicaments
HUP0102705A3 (en) Alpha-amino acid phenyl ester derivatives and their use and pharmaceutical compositions comprising them
AU6104498A (en) Active composition for combating the effects of the cold and cosmetic product containing this composition
TW394074U (en) Improved structure of in-line roller-skates
TW410558U (en) Improved structure of shoelace
AU2002361078A1 (en) Markers for sugar/lipid metabolic disorders and utilization thereof
TW355395U (en) Secure structure of leggings for in-line skates
GB9805675D0 (en) Preparation of solid lipid compositions